Photostabilized preparation comprising atropine-containing aqueous pharmaceutical composition and its photostabilization method

TW202641520APending Publication Date: 2026-10-16SANTEN PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147696
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-07-30
Filing Date
2025-12-05
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080663_001
    Figure TWG2TA001080663_001
  • Figure TWG2TA001080663_002
    Figure TWG2TA001080663_002
  • Figure TWG2TA001080663_003
    Figure TWG2TA001080663_003
Patent Text Reader

Abstract

This invention provides an ophthalmic pharmaceutical preparation and a method for stabilizing the same. The ophthalmic pharmaceutical preparation is an aqueous pharmaceutical composition contained in a direct package that is visible to the naked eye and blocks light of wavelengths from 210 to 380 nm. The aqueous pharmaceutical composition contains 0.001 to 0.1% (w / v) of atropine or its salt and exhibits excellent stability for specific wavelengths of light.
Need to check novelty before this filing date? Find Prior Art